Ex vivo 1H and 31P magnetic resonance spectroscopy as a means for tumor characterization in ovarian cancer patients

By        

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 321-328

Spandidos Publications

Access to resources Recommend Favorite

An HCG-rich microenvironment contributes to ovarian cancer cell differentiation into endothelioid cells in a three-dimensional culture system

By            

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2395-2402

Spandidos Publications

Access to resources Recommend Favorite

The detection of stage I ovarian cancer by three-dimensional sonography and power Doppler

By Kurjak A.   Kupesic S.   Sparac V.   Prka M.   Bekavac I.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 258-264

Elsevier

Access to resources Recommend Favorite

Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: ^{31}P and ^{13}C nuclear magnetic resonance studies

By Vivi A.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 15-25

Springer Publishing Company

Access to resources Recommend Favorite

³¹P magnetic resonance spectroscopy of the breast and the influence of the menstrual cycle

By Stehouwer B.   Kemp W.   Luijten P.   Bosch M.   Veldhuis W.   Wijnen J.   Klomp D.  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 583-589

Springer Publishing Company

Access to resources Recommend Favorite